Realcan Pharmaceutical Group Co., Ltd.
Shenzhen Stock Exchange 002589.SZ
Realcan Pharmaceutical Group Co., Ltd. Gross Profit Margin for the year ending December 31, 2023: 10.23%
-
Realcan Pharmaceutical Group Co., Ltd. Gross Profit Margin for the year ending December 31, 2022 was 13.58%, a -25.49% change year over year.
-
Realcan Pharmaceutical Group Co., Ltd. Gross Profit Margin for the year ending December 31, 2021 was 18.23%, a -0.36% change year over year.
-
Realcan Pharmaceutical Group Co., Ltd. Gross Profit Margin for the year ending December 31, 2020 was 18.29%, a -5.41% change year over year.
-
Realcan Pharmaceutical Group Co., Ltd. Gross Profit Margin for the year ending December 31, 2019 was 19.34%, a 1.02% change year over year.
| Date | Gross Profit Margin | Operating Income Margin | EBT Margin | Net Income Margin |
|---|
| CEO | Mr. Xu Han |
| IPO Date | June 10, 2011 |
| Location | China |
| Headquarters | No. 326, Airport Road |
| Employees | 3,239 |
| Sector | Health Care |
| Industries | |
Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institution worldwide. It sells drugs, vaccines, and medical devices. The company also provides medical logistics services; third-party logistics services; disinfection and sterilization; and lease, and hospital logistics services for medical institutions. It serves drug distribution, academic services, medical diagnosis, financial technology, traditional Chinese medicine, digital medical care, professional logistics, and comprehensive equipment. The company was formerly known as Realcan Pharmaceutical Co., Ltd. and changed its name to Realcan Pharmaceutical Group Co., Ltd. in December 2018. Realcan Pharmaceutical Group Co., Ltd. was founded in 2004 and is based in Yantai, China.
Past 5 years
USD 3.86
USD 2.84
USD 0.50
USD 1.90
USD 0.61
StockViz Staff
January 15, 2025
Any question? Send us an email